A people’s vaccine? Drugmakers set to profit from COVID vaccines made with publicly funded research

With the world pinning its hopes on a successful coronavirus vaccine to curb the pandemic, corporate watchdogs say much of the research and development of the medicines rely on publicly funded research. “The investment in these vaccines, as for most drugs, has really been underwritten by the taxpayer, by the government,” says Robert Weissman, president of Public Citizen.